Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer Y Wang, JD McKay, T Rafnar, Z Wang, MN Timofeeva, P Broderick, ... Nature genetics 46 (7), 736-741, 2014 | 468 | 2014 |
TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers F Le Calvez, A Mukeria, JD Hunt, O Kelm, RJ Hung, P Taniere, P Brennan, ... Cancer research 65 (12), 5076-5083, 2005 | 343 | 2005 |
Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST/IFCT-1002 S Couraud, F Vaca-Paniagua, S Villar, J Oliver, T Schuster, H Blanché, ... Clinical Cancer Research 20 (17), 4613-4624, 2014 | 269 | 2014 |
Tobacco smoking-associated genome-wide DNA methylation changes in the EPIC study S Ambatipudi, C Cuenin, H Hernandez-Vargas, A Ghantous, ... Epigenomics 8 (5), 599-618, 2016 | 240 | 2016 |
The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families MIW Achatz, M Olivier, F Le Calvez, G Martel-Planche, A Lopes, BM Rossi, ... Cancer letters 245 (1-2), 96-102, 2007 | 236 | 2007 |
Rare mutations in XRCC2 increase the risk of breast cancer DJ Park, F Lesueur, T Nguyen-Dumont, M Pertesi, F Odefrey, F Hammet, ... The American Journal of Human Genetics 90 (4), 734-739, 2012 | 226 | 2012 |
Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors H Hernandez-Vargas, MP Lambert, F Le Calvez-Kelm, G Gouysse, ... PloS one 5 (3), e9749, 2010 | 224 | 2010 |
Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer SV Tavtigian, PJ Oefner, D Babikyan, A Hartmann, S Healey, ... The American Journal of Human Genetics 85 (4), 427-446, 2009 | 217 | 2009 |
Identification of circulating tumor DNA for the early detection of small-cell lung cancer L Fernandez-Cuesta, S Perdomo, PH Avogbe, N Leblay, TM Delhomme, ... EBioMedicine 10, 117-123, 2016 | 209 | 2016 |
Determining the effectiveness of High Resolution Melting analysis for SNP genotyping and mutation scanning at the TP53 locus S Garritano, F Gemignani, C Voegele, T Nguyen-Dumont, ... BMC genetics 10, 1-12, 2009 | 189 | 2009 |
DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility S Ambatipudi, S Horvath, F Perrier, C Cuenin, H Hernandez-Vargas, ... European journal of cancer 75, 299-307, 2017 | 178 | 2017 |
Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect S Garritano, F Gemignani, EI Palmero, M Olivier, G Martel‐Planche, ... Human mutation 31 (2), 143-150, 2010 | 176 | 2010 |
Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids N Alcala, N Leblay, AAG Gabriel, L Mangiante, D Hervás, T Giffon, ... Nature communications 10 (1), 3407, 2019 | 163 | 2019 |
MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells M Ouzounova, T Vuong, PB Ancey, M Ferrand, G Durand, ... BMC genomics 14, 1-15, 2013 | 154 | 2013 |
Rare key functional domain missense substitutions in MRE11A, RAD50, and NBNcontribute to breast cancer susceptibility: results from a Breast Cancer Family … F Damiola, M Pertesi, J Oliver, F Le Calvez-Kelm, C Voegele, EL Young, ... Breast Cancer Research 16, 1-16, 2014 | 143 | 2014 |
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing DF Easton, F Lesueur, B Decker, K Michailidou, J Li, J Allen, C Luccarini, ... Journal of medical genetics 53 (5), 298-309, 2016 | 142 | 2016 |
Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non–small cell lung cancers in relation to smoking history M Mounawar, A Mukeria, F Le Calvez, RJ Hung, H Renard, A Cortot, ... Cancer research 67 (12), 5667-5672, 2007 | 142 | 2007 |
Human Papillomavirus Type 16 and TP53 Mutation in Oral Cancer: Matched Analysis of the IARC Multicenter Study M Dai, GM Clifford, F le Calvez, X Castellsagué, PJF Snijders, M Pawlita, ... Cancer research 64 (2), 468-471, 2004 | 137 | 2004 |
Integrative genome-wide gene expression profiling of clear cell renal cell carcinoma in Czech Republic and in the United States MB Wozniak, F Le Calvez-Kelm, B Abedi-Ardekani, G Byrnes, G Durand, ... PloS one 8 (3), e57886, 2013 | 130 | 2013 |
Genome-wide association study identifies multiple risk loci for renal cell carcinoma G Scelo, MP Purdue, KM Brown, M Johansson, Z Wang, JE Eckel-Passow, ... Nature communications 8 (1), 15724, 2017 | 125 | 2017 |